BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 12491081)

  • 1. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study.
    So JB; Yeoh KG; Moochala S; Chachlani N; Ho J; Wong WK; Mack P; Goh PM
    Gastric Cancer; 2002; 5(4):228-32. PubMed ID: 12491081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
    Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
    Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China.
    Sun LP; Gong YH; Wang L; Yuan Y
    World J Gastroenterol; 2007 Dec; 13(48):6562-7. PubMed ID: 18161928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
    Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.
    Sato Y; Iwafuchi M; Ueki J; Yoshimura A; Mochizuki T; Motoyama H; Sugimura K; Honma T; Narisawa R; Ichida T; Asakura H; Van Thiel DH
    Dig Dis Sci; 2002 Mar; 47(3):579-85. PubMed ID: 11911346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
    Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic and serum risk markers for noncardia early gastric cancer.
    Shiotani A; Iishi H; Uedo N; Kumamoto M; Nakae Y; Ishiguro S; Tatsuta M; Graham DY
    Int J Cancer; 2005 Jun; 115(3):463-9. PubMed ID: 15688378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia.
    Kumar S; Kumari N; Mittal RD; Ghoshal UC
    Gastric Cancer; 2016 Jul; 19(3):808-16. PubMed ID: 26486507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.
    Kitamura Y; Yoshihara M; Ito M; Boda T; Matsuo T; Kotachi T; Tanaka S; Chayama K
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1473-7. PubMed ID: 25974661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection.
    Di Mario F; Moussa AM; Caruana P; Merli R; Cavallaro LG; Cavestro GM; Dal Bò N; Iori V; Pilotto A; Leandro G; Franzè A; Rugge M
    Scand J Gastroenterol; 2003 Dec; 38(12):1223-7. PubMed ID: 14750641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
    Paik CN; Chung IS; Nam KW; Kwon JH; Chang JH; Suh JP; Park JM; Cho YK; Lee IS; Kim SW; Choi MG
    Korean J Gastroenterol; 2007 Aug; 50(2):84-91. PubMed ID: 17928751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
    Reshetnikov OV; Openko TG; Simonova GI; Kurilovich SA; Maliushina SK; Ragino IuI; Voevoda MI
    Vopr Onkol; 2012; 58(5):644-8. PubMed ID: 23600281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
    Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.